production
Skip to Content

MT5024: MOLECULAR PHARMACOLOGY (2016-2017)

Last modified: 28 Jun 2018 10:27


Course Overview

This course will cover a wide range of topics and will include revision of receptor theory and intra- and inter- cellular communication.  Cancer will be used a s model disease and the molecular basis of cancer, how it is treated, clinical issues, drug resistance and chemotherapy and prevention

Course Details

Study Type Postgraduate Level 5
Session First Sub Session Credit Points 15 credits (7.5 ECTS credits)
Campus None. Sustained Study No
Co-ordinators
  • Professor Heather Wallace

Qualification Prerequisites

None.

What courses & programmes must have been taken before this course?

  • One of Any Postgraduate Programme (Studied) or MSc Clinical Pharmacology (Studied) or MSc Drug Discovery and Development (Studied)

What other courses must be taken with this course?

None.

What courses cannot be taken with this course?

  • MT5008 Molecular Pharmacology (Studied)

Are there a limited number of places available?

No

Course Description

This course will cover aspects of receptor pharmacology, immunopharmacology, cancer biology, molecular carcinogenesis, chemotherapy, chemoprevention, clinical trials and ethics.


In light of Covid-19 this information is indicative and may be subject to change.

Contact Teaching Time

Information on contact teaching time is available from the course guide.

Teaching Breakdown

None.

More Information about Week Numbers


Summative Assessments

Continuous assessment (data handling practical, a multiple choice questionaire, cell culture practical, 3000 word essay (50%)); written exam (50%).

Formative Assessment

There are no assessments for this course.

Feedback

None.

Course Learning Outcomes

None.

Compatibility Mode

We have detected that you are have compatibility mode enabled or are using an old version of Internet Explorer. You either need to switch off compatibility mode for this site or upgrade your browser.